[1] |
Adams MM, Elam-Evans LD, Wilson HG, et al. Rates of and factors associated with recurrence of preterm delivery[J]. JAMA, 2000, 283(12):1591-1596. doi: 10.1001/jama.283.12.1591.
|
[2] |
Ohuma EO, Moller AB, Bradley E, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis[J]. Lancet, 2023, 402(10409):1261-1271. doi: 10.1016/S0140-6736(23)00878-4.
pmid: 37805217
|
[3] |
Esplin MS, Elovitz MA, Iams JD, et al. Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women[J]. JAMA, 2017, 317(10):1047-1056. doi: 10.1001/jama.2017.1373.
pmid: 28291893
|
[4] |
Society for Maternal-Fetal Medicine (SMFM). SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth[J]. Am J Obstet Gynecol, 2024, 231(2):B2-B13. doi: 10.1016/j.ajog.2024.05.006.
|
[5] |
AIUM-ACR-ACOG-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examina-tions[J]. J Ultrasound Med, 2018, 37(11):E13-E24. doi: 10.1002/jum.14831.
|
[6] |
Friedman AM, Schwartz N, Ludmir J, et al. Can transabdominal ultrasound identify women at high risk for short cervical length?[J]. Acta Obstet Gynecol Scand, 2013, 92(6):637-641. doi: 10.1111/aogs.12111.
|
[7] |
Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234[J]. Obstet Gynecol, 2021, 138(2):e65-e90. doi: 10.1097/AOG.0000000000004479.
|
[8] |
Songserm V, Komwilaisak R, Saksiriwuttho P, et al. Transperineal versus transvaginal sonographic measurements of cervical length in pregnant women between 16 and 24 weeks of gestation[J]. J Clin Ultrasound, 2019, 47(7):389-393. doi: 10.1002/jcu.22640.
|
[9] |
McIntosh J, Feltovich H, Berghella V, et al. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention[J]. Am J Obstet Gynecol, 2016, 215(3):B2-B7. doi: 10.1016/j.ajog.2016.04.027.
|
[10] |
Heath VC, Southall TR, Souka AP, et al. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery[J]. Ultrasound Obstet Gynecol, 1998, 12(5):312-317. doi: 10.1046/j.1469-0705.1998.12050312.x.
|
[11] |
Vaisbuch E, Romero R, Mazaki-Tovi S, et al. The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester[J]. Am J Obstet Gynecol, 2010, 203(5):446.e1-446.e9. doi: 10.1016/j.ajog.2010.05.040.
|
[12] |
Leung TN, Pang MW, Leung TY, et al. Cervical length at 18-22 weeks of gestation for prediction of spontaneous preterm delivery in Hong Kong Chinese women[J]. Ultrasound Obstet Gynecol, 2005, 26(7):713-717. doi: 10.1002/uog.2617.
|
[13] |
Guzman ER, Walters C, Ananth CV, et al. A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton gestations[J]. Ultrasound Obstet Gynecol, 2001, 18(3):204-210. doi: 10.1046/j.0960-7692.2001.00526.x.
|
[14] |
Fonseca EB, Celik E, Parra M, et al. Progesterone and the risk of preterm birth among women with a short cervix[J]. N Engl J Med, 2007, 357(5):462-469. doi: 10.1056/NEJMoa067815.
|
[15] |
Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial[J]. Ultrasound Obstet Gynecol, 2011, 38(1):18-31. doi: 10.1002/uog.9017.
pmid: 21472815
|
[16] |
Epppic Group. Evaluating Progestogens for Preventing preterm birth International Collaborative(EPPPIC): meta-analysis of individual participant data from randomised controlled trials[J]. Lancet, 2021,397:1183-1194. doi: 10.1016/s0140-6736(21)00217-8.
|
[17] |
Romero R, Conde-Agudelo A, Da Fonseca E, et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data[J]. Am J Obstet Gynecol, 2018, 218(2):161-180. doi: 10.1016/j.ajog.2017.11.576.
|
[18] |
Rosta K, Ott J, Kelemen F, et al. Is vaginal progesterone treatment associated with the development of gestational diabetes? A retrospective case-control study[J]. Arch Gynecol Obstet, 2018, 298(6):1079-1084. doi: 10.1007/s00404-018-4895-1.
pmid: 30225687
|
[19] |
Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate[J]. N Engl J Med, 2003, 348(24):2379-2385. doi: 10.1056/NEJMoa035140.
|
[20] |
Grobman WA, Thom EA, Spong CY, et al. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm[J]. Am J Obstet Gynecol, 2012, 207(5):390.e1-390.e8. doi: 10.1016/j.ajog.2012.09.013.
|
[21] |
Society for Maternal-Fetal Medicine Statement: Response to the Food and Drug Administration′s withdrawal of 17-alpha hydroxyprogesterone caproate[J]. Am J Obstet Gynecol, 2023, 229(1):B2-B6. doi: 10.1016/j.ajog.2023.04.012.
|
[22] |
Shennan AH, Story L. Cervical Cerclage: Green-top Guideline No.75[J]. BJOG, 2022, 129(7):1178-1210. doi: 10.1111/1471-0528.17003.
|
[23] |
To MS, Alfirevic Z, Heath VC, et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial[J]. Lancet, 2004, 363(9424):1849-1853. doi: 10.1016/S0140-6736(04)16351-4.
pmid: 15183621
|
[24] |
Berghella V, Ciardulli A, Rust OA, et al. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data[J]. Ultrasound Obstet Gynecol, 2017, 50(5):569-577. doi: 10.1002/uog.17457.
pmid: 28295722
|
[25] |
Boelig RC, Dugoff L, Roman A, et al. Predicting asymptomatic cervical dilation in pregnant patients with short mid-trimester cervical length: A secondary analysis of a randomized controlled trial[J]. Acta Obstet Gynecol Scand, 2019, 98(6):761-768. doi: 10.1111/aogs.13545.
|
[26] |
Zafman KB, Rebarber A, Fox NS. Serial Cervical Length Evaluation in Low-Risk Women with Shortened Cervical Lengths in the Midtrimester: How Many Will Dilate Prior to 24 Weeks?[J]. Am J Perinatol, 2020, 37(1):14-18. doi: 10.1055/s-0039-1694006.
pmid: 31398731
|
[27] |
薛志伟, 刘亚娜, 王棵, 等. 宫颈托预防自发性早产的单中心前瞻性队列研究[J]. 四川大学学报(医学版), 2024, 55(4):1007-1013. doi: 10.12182/20240760501.
|
[28] |
Saccone G, Maruotti GM, Giudicepietro A, et al. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial[J]. JAMA, 2017, 318(23):2317-2324. doi: 10.1001/jama.2017.18956.
pmid: 29260226
|
[29] |
Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA, et al. Cervical pessary for preventing preterm birth in singleton pregnancies[J]. Cochrane Database Syst Rev, 2022, 12(12):CD014508. doi: 10.1002/14651858.CD014508.
|
[30] |
Conde-Agudelo A, Romero R, Nicolaides KH. Cervical pessary to prevent preterm birth in asymptomatic high-risk women: a systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2020, 223(1):42-65.e2. doi: 10.1016/j.ajog.2019.12.266.
pmid: 32027880
|
[31] |
Brizot ML, Hernandez W, Liao AW, et al. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study[J]. Am J Obstet Gynecol, 2015, 213(1):82.e1-82.e9. doi: 10.1016/j.ajog.2015.02.021.
|
[32] |
Norman JE, Norrie J, MacLennan G, et al. Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysis[J]. PLoS Med, 2021, 18(3):e1003506. doi: 10.1371/journal.pmed.1003506.
|
[33] |
Roman A, Zork N, Haeri S, et al. Physical examination-indicated cerclage in twin pregnancy: a randomized controlled trial[J]. Am J Obstet Gynecol, 2020, 223(6):902.e1-902.e11. doi: 10.1016/j.ajog.2020.06.047.
|
[34] |
Brown R, Gagnon R, Delisle MF. No.373-Cervical Insufficiency and Cervical Cerclage[J]. J Obstet Gynaecol Can, 2019, 41(2):233-247. doi: 10.1016/j.jogc.2018.08.009.
|